ALKEM LABORATORIES
Back to Income Statement
|
ALKEM LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹2,165 Cr | ₹1,796 Cr | ₹984 Cr | ₹1,646 Cr | ₹1,585 Cr |
What is the latest Consolidated Net Profit of ALKEM LABORATORIES ?
Year | Consolidated Net Profit |
---|---|
Mar2025 | ₹2,165 Cr |
Mar2024 | ₹1,796 Cr |
Mar2023 | ₹984 Cr |
Mar2022 | ₹1,646 Cr |
Mar2021 | ₹1,585 Cr |
How is Consolidated Net Profit of ALKEM LABORATORIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2025 | ₹2,165 Cr | 20.59 | |
Mar2024 | ₹1,796 Cr | 82.47 | |
Mar2023 | ₹984 Cr | -40.19 | |
Mar2022 | ₹1,646 Cr | 3.82 | |
Mar2021 | ₹1,585 Cr | - |
Compare Consolidated Net Profit of peers of ALKEM LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALKEM LABORATORIES | ₹58,541.8 Cr | -3% | 1.6% | -5.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹168,811.0 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,786.0 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics |
ALKEM LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALKEM LABORATORIES | -3% |
1.6% |
-5.3% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses